Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (23 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net sales
13
10
3
3
4
3
Cost of sales
4
2
1
1
1
1
Gross Profit
9
7
2
2
2
2
Research and development
0
0
0
0
0
0
Sales and Marketing
2
2
1
1
1
0
General and administrative
5
5
2
1
1
1
Depreciation and amortization
1
1
0
0
0
0
Total operating expenses
8
8
3
2
2
2
Operating income (loss)
0
-1
-2
-1
0
0
Gain on sale of Investment in GlamSmile Asia Ltd. (Note 3)
0
0
0
2
0
0
Gain on sale of Asset Remedent OTC BV (Note 3)
0
2
0
0
0
0
Equity income from investments
0
0
0
0
0
0
Impairment of long-term investments and advances (Note 11 )
-1
0
0
0
0
0
Interest expense
0
0
0
0
0
0
Interest income
0
0
0
0
0
0
Other expense
0
0
0
0
0
0
Total other income
-1
2
1
1
0
0
PROFIT (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
-1
2
-1
1
0
0
Income tax expense
0
0
0
0
0
0
Net Income (Loss)
-1
1
-1
0
0
0
NET INCOME BEFORE NON-CONTROLLING INTEREST
0
0
0
1
0
0
Net income attributable to non-controlling interest
-1
-1
0
0
0
0
NET INCOME ATTRIBUTABLE TO REMEDENT INC. COMMON SHAREHOLDERS
-2
0
0
1
0
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Jul 15, 2013 n/a
calculated values,
restated on Jul 14, 2014 n/a
calculated values,
restated on Jun 29, 2015 n/a
calculated values,
restated on Jun 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
2
0
0
1
0
0
Accounts receivable, net of allowance for doubtful accounts of $85,938 at March 31, 2016 and $50,089 at March 31, 2015
3
1
1
1
1
1
Other receivable
0
0
0
1
1
1
Inventories, net
2
1
1
1
0
0
Prepaid Expense
1
1
1
0
0
0
Total current assets
7
3
3
3
3
3
Property and equipment, net
1
1
1
0
0
0
Investment in GlamSmile Asia Ltd
0
2
2
1
1
2
Investment in MFI (Note 3)
0
0
1
1
1
1
Goodwill (Note 3)
1
0
0
0
0
0
Investment in Remedent OTC BV (Note 3)
0
1
0
0
0
0
Patents, net
0
0
0
0
0
0
Total assets
10
7
7
6
6
6
Liabilities and owners' equity
Current portion, long term debt
0 184679
1 863501
1 1214266
2 2257403
2 2172467
2 2222468
Line of credit
2 2160674
1 1079263
1 836355
0 273200
0 0
0 0
Short term loan (Note 4)
0 400000
0 0
0 0
0 0
0 0
0 0
Accounts payable
2 1744253
1 1009176
1 971814
1 598558
1 846773
1 789270
Accrued liabilities
1 1256148
1 536331
1 737064
0 450303
0 334748
0 347857
Deferred revenue
0 475250
0 57254
0 149129
0 124251
0 87747
0 73431
Due to related parties (Note 3)
0 95354
0 61836
0 0
0 145909
0 0
0 0
Total current liabilities
6 6316358
4 3607361
4 3908628
4 3849624
3 3441735
3 3433026
Long term debt less current portion
0 273557
1 1452523
1 1131364
0 0
0 0
0 0
Total liabilities
7 6589915
5 5059884
5 5039992
0 0
0 0
0 0
Preferred Stock $0.001 par value (10,000,000 shares authorized, none issued and outstanding)
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $0.001 par value; (50,000,000 shares authorized, 19,995,969 shares issued and outstanding at March 31, 2016 and March 31, 2015 respectively)
0 19996
0 19996
0 19996
0 19996
0 19996
0 19996
Treasury stock, at cost; 723,000 shares outstanding at March 31, 2016 and March 31, 2015 respectively
-1 -831450
-1 -831450
-1 -831450
-1 -831450
-1 -831450
-1 -831450
Additional paid-in capital
25 24855883
25 24906269
25 24906269
25 24906269
25 24906269
25 24906269
Accumulated deficit
-21 -21113118
-21 -20622635
-22 -21604571
-21 -21080063
-21 -20974904
-21 -20814102
Accumulated other comprehensive income (loss)
-1 -834949
-2 -1681829
-1 -1118262
-1 -793382
-1 -1185097
-1 -1195181
Obligation to issue shares (Note 3)
0 97500
0 97500
0 97500
0 97500
0 97500
0 97500
Total Remedent, Inc. stockholders’ equity
2 2193862
2 1887851
1 1469482
2 2318870
2 2032314
2 2183032
Non-controlling interest
1 838509
0 17362
0 17362
0 0
0 70747
0 86734
Total stockholders’ equity
3 3032371
2 1905213
1 1486844
2 2318870
2 2103061
2 2269766
Total liabilities and equity
10 9622286
7 6965097
7 6526836
6 6168494
6 5544796
6 5702792
COMMITMENTS (Note 21)
0 0
0 0
0 0
0 0
0 0
0 0
Remarks restated on Nov 30, -1 n/a restated on Jul 15, 2013 n/a restated on Nov 30, -1 n/a restated on Jun 29, 2015 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net profit
-1
1
-1
1
0
0
Gain on Sale of Glamsmile Asia (note 3)
0
-1
0
-2
0
0
Non cash revenue
0
0
0
0
0
0
Gain on sale of Remedent OTC B.V.
0
-2
0
0
0
0
Depreciation and amortization
1
1
0
0
0
0
Inventory reserve
0
0
0
0
0
0
Allowance for doubtful accounts
0
0
0
0
0
0
Value of stock options issued to employees and consultants
0
0
0
0
0
0
Other non-cash income
0
0
0
0
0
0
Impairment of long-term investments and advances
1
0
0
0
0
0
Investment income
0
0
0
0
0
0
Gain on investment
0
0
0
0
0
0
Accounts receivable
-2
1
0
0
0
0
Inventories
0
0
0
0
0
0
Prepaid expenses
0
-1
1
0
0
0
Accrued interest on long term debt
0
0
0
0
0
0
Accounts payable
0
0
0
0
0
0
Accrued liabilities
1
-1
0
0
0
0
Due to related parties
0
0
0
0
0
0
Deferred revenue
0
1
0
0
0
0
Net cash used by operating activities
0
0
-1
0
0
0
Proceeds on sale of Remedent OTC BV
0
0
1
0
0
0
Cash divested on deconsolidation of Remedent OTC B.V.
0
-2
0
0
0
0
Cash divested on deconsolidation of GlamSmile Asia
0
-1
0
0
0
0
Purchases of patent rights
0
0
0
0
0
0
Purchases of equipment
0
0
0
0
0
0
Net cash used by investing activities
-1
-4
1
0
0
0
Short term loan
0
1
0
0
0
0
Proceeds from sale of investment in GlamSmile Asia (Note 3)
0
2
0
2
0
0
Repayments of capital lease note payable
0
0
0
0
0
0
(Repayments) of line of credit
1
0
0
-1
0
0
Net cash provided by financing activities
2
3
0
1
0
0
Net (decrease) in cash
1
-1
0
1
0
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Jul 15, 2013 n/a
calculated values,
restated on Jul 14, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 29, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,